Exalpha Biologicals, Inc. Announces Acquisition of Leading Producer of Egg-Derived Antibodies Gallus Immunotech Inc.
Shirley, Massachusetts, USA – June 6th, 2018 – Exalpha Biologicals, Inc., founded over 20 years ago and dedicated to accelerating the pace of discovery in the life science arena announces the acquisition of Gallus Immunotech Inc., which is effective from today 6th June 2018.
